(Q44647938)

5 December 2017

title

Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy (English)

1 reference

5 December 2017

Greenberg SM

1

1 reference

5 December 2017

Cho HS

2

1 reference

5 December 2017

O'Donnell HC

3

1 reference

5 December 2017

Rosand J

4

1 reference

5 December 2017

Segal AZ

5

1 reference

5 December 2017

Younkin LH

6

1 reference

5 December 2017

Younkin SG

7

1 reference

5 December 2017

Rebeck GW

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Annals of the New York Academy of Sciences

5 December 2017

published in

1 reference

5 December 2017

volume

903

1 reference

5 December 2017

page(s)

144-149

1 reference

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Circulating transforming growth factor beta 1 and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

Low Cholesterol as a Risk Factor for Primary Intracerebral Hemorrhage: A Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06361.X

10.1111/J.1749-6632.2000.TB06361.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference